Skip to main content

Research Repository

Advanced Search

REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease

Barth, Sarah; Edwards, Colin; Borton, Rebecca; Beever, Daniel; Adams, Wendy; Jenkins, Gisli; Pizzo, Elena; Stewart, Iain; Wickremasinghe, Melissa

REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease Thumbnail


Authors

Sarah Barth

Colin Edwards

Rebecca Borton

Wendy Adams

Gisli Jenkins

Elena Pizzo

Iain Stewart

Melissa Wickremasinghe



Abstract

Introduction Remote monitoring of home physiological measurements has been proposed as a solution to support patients with chronic diseases as well as facilitating virtual consultations and pandemic preparedness for the future. Daily home spirometry and pulse oximetry have been demonstrated to be safe and acceptable to patients with interstitial lung disease (ILD) but there is currently limited evidence to support its integration into clinical practice. Aim Our aim is to understand the clinical utility of frequent remote physiological measurements in ILD and the impact of integrating these into clinical practice from a patient, clinical and health economic perspective. Methods and analysis 132 patients with fibrotic ILD will be recruited and randomised to receive either usual care with remote digital monitoring of home spirometry and pulse oximetry or usual care alone for 12 months. All participants will complete health-related quality of life and experience questionnaires. The primary outcome compares the availability of spirometry measurements within the 2 weeks preceding planned clinic appointments. Secondary outcomes will explore other aspects of clinical and cost-effectiveness of the remote monitoring programme. Ethics and dissemination The study has been approved by the Camden and Kings Cross Research Ethics Committee (22/LO/0309). All participants will provide informed consent. This study is registered with www.clinicaltrials.gov (NCT05662124). The results of the study will be submitted for presentation at regional and national conferences and submitted for peer-reviewed publication. Reports will be prepared for study participants with the support from our public involvement representatives through the charity Action for Pulmonary Fibrosis.

Citation

Barth, S., Edwards, C., Borton, R., Beever, D., Adams, W., Jenkins, G., Pizzo, E., Stewart, I., & Wickremasinghe, M. (2024). REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease. BMJ Open Respiratory Research, 11(1), Article e002067. https://doi.org/10.1136/bmjresp-2023-002067

Journal Article Type Article
Acceptance Date Nov 14, 2023
Online Publication Date Feb 28, 2024
Publication Date Feb 28, 2024
Deposit Date Apr 12, 2024
Publicly Available Date Apr 15, 2024
Journal BMJ Open Respiratory Research
Electronic ISSN 2052-4439
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 11
Issue 1
Article Number e002067
DOI https://doi.org/10.1136/bmjresp-2023-002067
Keywords Pulmonary and Respiratory Medicine
Public URL https://nottingham-repository.worktribe.com/output/33027265
Publisher URL https://bmjopenrespres.bmj.com/content/11/1/e002067

Files





You might also like



Downloadable Citations